| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |